Market Overview

Myomo to Report Third Quarter 2018 Results on November 5, 2018


Management to hold a conference call at 4:30 p.m. EST

Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable
medical robotics company, today announced that it will release its
financial results for the third quarter 2018 on Monday, November 5,
2018, after the US markets close.

The Company will host a conference call on Monday, November 5, 2018 at
4:30 p.m. EST featuring remarks by Paul R. Gudonis, Chairman and Chief
Executive Officer, and Ralph A. Goldwasser, Chief Financial Officer. The
conference call, webcast and accompanying slides can be accessed through
Myomo's Investor
page. Please allow extra time prior to the call to visit
the site and download any necessary software to listen to the live

To dial into the conference call, please dial 1-877-270-2148 from the
U.S. or 1-412-902-6510 internationally. A replay of the conference call
will be available approximately one hour after completion of the live
conference call at the Investor
page. A dial-in replay of the call will be available until
November 19, 2018; please dial 1-877-344-7529 from the U.S. or
1-412-317-0088 internationally and provide the passcode of 10125914.

About Myomo
Myomo, Inc. is a wearable medical robotics
company that offers expanded mobility for those suffering from
neurological disorders and upper limb paralysis. Myomo develops and
markets the MyoPro product line. MyoPro is a powered upper limb orthosis
designed to support the arm and restore function to the weakened or
paralyzed arms of patients suffering from CVA stroke, brachial plexus
injury, traumatic brain or spinal cord injury, ALS or other
neuromuscular disease or injury. It is currently the only marketed
device that, sensing a patient's own EMG signals through non-invasive
sensors on the arm, can restore an individual's ability to perform
activities of daily living, including feeding themselves, carrying
objects and doing household tasks. Many are able to return to work, live
independently and reduce their cost of care. Myomo is headquartered in
Cambridge, Massachusetts, with sales and clinical professionals across
the U.S. For more information, please visit

View Comments and Join the Discussion!